Surgical Outcomes After Debulking Surgery for Intraabdominal Ovarian Growing Teratoma Syndrome: Analysis of 38 Cases

Annals of Surgical Oncology

Volumn 22, Issue , 2015, Pages 964-970

  Bentivegna, Enrica ^a   Azaïs, Henri ^a   Uzan, Catherine ^a,b   Leary, Alexandra ^a   Pautier, Patricia ^a   Gonthier, Clementine ^a   Genestie, Catherine ^a   Balleyguier, Corinne ^a   Lhomme, Catherine ^a   Duvillard, Pierre ^a   Morice, Philippe ^a,b,c   Gouy, Sebastien ^a  

^a Gustave Roussy ^*  (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; FEMALE; FOLLOW UP; GERM CELL TUMOR; GLIA; GLIOSIS; HUMAN; INTESTINE RESECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARIAN GROWING TERATOMA SYNDROME; OVARY TERATOMA; RECTOUTERINE POUCH; SALPINGOOOPHORECTOMY; SPLENECTOMY; SYNDROME; TREATMENT OUTCOME; ADOLESCENT; CANCER GRADING; CANCER STAGING; CHILD; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; OVARIAN NEOPLASMS; PATHOLOGY; PERITONEUM; PREGNANCY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TERATOMA; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CYTOREDUCTION SURGICAL PROCEDURES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM GRADING; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; OVARIAN NEOPLASMS; PERITONEUM; PREGNANCY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TERATOMA; YOUNG ADULT;

EID: 84952874084     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-015-4608-y     Document Type: Article

References (32)

1. Logothetis CJ, Samuels ML, Trindade A, et al. The growing teratoma syndrome. Cancer. 1982;50:1629–35.
2. DiSaia PJ, Saltz A, Kagan AR, et al. Chemotherapeutic retroconversion of immature teratoma of the ovary. Obstet Gynecol. 1977;49:346–50.
3. Kattan J, Droz JP, Culine S, et al. The growing teratoma syndrome: a woman with nonseminomatous germ cell tumor of the ovary. Gynecol Oncol. 1993;49:395–9.
4. Tonkin KS, Rustin GJ, Wignall B, et al. Successful treatment of patients in whom germ cell tumour masses enlarged on chemotherapy while their serum tumour markers decreased. Eur J Cancer Clin Oncol. 1989;25:1739–43.
5. Amsalem H, Nadjari M, Prus D, et al. Growing teratoma syndrome vs chemotherapeutic retroconversion: case report and review of the literature. Gynecol Oncol. 2004;92:357–60.
6. Djordjevic B, Euscher ED, Malpica A. Growing teratoma syndrome of the ovary: review of literature and first report of a carcinoid tumor arising in a growing teratoma of the ovary. Am J Surg Pathol. 2007;31:1913–8.
7. David YB, Weiss A, Shechtman L, et al. Tumor chemoconversion following surgery, chemotherapy, and normalization of serum tumor markers in a woman with a mixed type germ cell ovarian tumor. Gynecol Oncol. 2002;84:464–7.
8. Robboy SJ, Scully RE. Ovarian teratoma with glial implants on the peritoneum: an analysis of 12 cases. Hum Pathol. 1970;1:643–53.
9. Norris HJ, Zirkin HJ, Benson WL. Immature (malignant) teratoma of the ovary: a clinical and pathologic study of 58 cases. Cancer. 1976;37:2359–72.
10. Truong LD, Jurco S III, McGavran MH. Gliomatosis peritonei: report of two cases and review of literature. Am J Surg Pathol. 1982;6:443–9.
11. Bentivegna E, Gonthier C, Uzan C, Genestie C, Morice P, Gouy S. Gliomatosis peritonei: a particular entity with specific outcomes within growing teratoma syndrome. Int J Gynecol Cancer. 2015;25:244–9.
12. Harms D, Jänig U, Göbel U. Gliomatosis peritonei in childhood and adolescence: clinicopathological study of 13 cases including immunohistochemical findings. Pathol Res Pract. 1989;184:422–30.
13. Nielsen SN, Scheithauer BW, Gaffey TA. Gliomatosis peritonei. Cancer. 1985;56:2499–503.
14. André F, Fizazi K, Culine S, et al. The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients. Eur J Cancer. 2000;36:1389–94.
15. Zagame L, Pautier P, Duvillard P, et al. Growing teratoma syndrome after ovarian germ cell tumors. Obstet Gynecol. 2006;108(3 Pt 1):509–14.
16. Cheng NH, Huang HF, Lian LJ, et al. Ovarian growing teratoma syndrome clinical study of 22 cases. Zhonghua Fu Chan Ke Za Zhi. 2009;44:426–30.
17. Sella A, el Naggar A, Ro JY, et al. Evidence of malignant features in histologically mature teratoma. J Urol. 1991;146:1025–8.
18. Stella M, Gandini A, Meeus P, et al. Retroperitoneal vascular surgery for the treatment of giant growing teratoma syndrome. Urology. 2012;79:365–70.
19. Sonneveld DJ, Sleijfer DT, Koops HS, et al. Mature teratoma identified after postchemotherapy surgery in patients with disseminated nonseminomatous testicular germ cell tumors: a plea for an aggressive surgical approach. Cancer. 1998;82:1343–51.
20. Gelderman WA, Schraffordt Koops H, Sleijfer DT, et al. Results of adjuvant surgery in patients with stage III and IV nonseminomatous testicular tumors after cisplatin-vinblastine-bleomycin chemotherapy. J Surg Oncol. 1988;38:227–32.
21. Gelderman WA, Koops HS, Sleijfer DT, et al. Treatment of retroperitoneal residual tumor after PVB chemotherapy of nonseminomatous testicular tumors. Cancer. 1986;58:1418–21.
22. Loehrer PJ Sr, Hui S, Clark S, et al. Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors: a clinicopathological correlation. J Urol. 1986;135:1183–9.
23. Williams S, Blessing JA, Liao SY, et al. Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group. J Clin Oncol. 1994;12:701–6.
24. Bonazzi C, Peccatori F, Colombo N, et al. Pure ovarian immature teratoma, a unique and curable disease: 10 years’ experience of 32 prospectively treated patients. Obstet Gynecol. 1994;84:598–604.
25. Geisler JP, Goulet R, Foster RS, et al. Growing teratoma syndrome after chemotherapy for germ cell tumors of the ovary. Obstet Gynecol. 1994;84(4 Pt 2):719–21.
26. Itani Y, Kawa M, Toyoda S, et al. Growing teratoma syndrome after chemotherapy for a mixed germ cell tumor of the ovary. J Obstet Gynaecol Res. 2002;28:166–71.
27. Lorusso D, Malaguti P, Trivellizzi IN, et al. Unusual liver locations of growing teratoma syndrome in ovarian malignant germ cell tumors. Gynecol Oncol Case Rep. 2011;1:24–5.
28. Lee CW, Song MJ, Park ST, et al. Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: a retrospective study of single institution. World J Surg Oncol. 2011;9:123.
29. Pendlebury A, Rischin D, Ireland-Jenkin K, et al. Ovarian growing teratoma syndrome with spuriously elevated α-fetoprotein. J Clin Oncol. 2014. doi:10.1200/JCO.2013.49.8998.
30. Lhomme C, Leary A, Uzan C, et al. Adjuvant chemotherapy in stage I ovarian germ cells tumors: should indications and treatment modalities be different in young girls and adults? J Clin Oncol. 2014;32(25):2815–6.
31. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.
32. Jeffery GM, Theaker JM, Lee AH, et al. The growing teratoma syndrome. Br J Urol. 1991;67:195–202.